Description
NSI-189 is a benzylpiperazine-aminopyridine compound known for its interaction with neurogenic and neurotrophic pathways. It is structurally classified as a pyridine-based small molecule with a high degree of lipophilicity, contributing to its molecular stability and bioavailability. This compound undergoes hepatic metabolism via oxidation and conjugation, with primary clearance occurring through renal and biliary excretion.
There are no reviews yet.